位置:首页 > 蛋白库 > IHH_HUMAN
IHH_HUMAN
ID   IHH_HUMAN               Reviewed;         411 AA.
AC   Q14623; B9EGM5; O43322; Q8N4B9;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2003, sequence version 4.
DT   03-AUG-2022, entry version 218.
DE   RecName: Full=Indian hedgehog protein {ECO:0000305};
DE            Short=IHH;
DE            EC=3.1.-.- {ECO:0000250|UniProtKB:Q62226};
DE   AltName: Full=HHG-2;
DE   Contains:
DE     RecName: Full=Indian hedgehog protein N-product;
DE   Flags: Precursor;
GN   Name=IHH {ECO:0000312|HGNC:HGNC:5956};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tate G., Kishimoto K., Mitsuya T.;
RT   "Expression of Sonic hedgehog and its receptor Patched/Smoothened in human
RT   cancer cell lines and embryonic organs.";
RL   J. Biochem. Mol. Biol. Biophys. 4:27-34(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 100-411.
RC   TISSUE=Fetal lung;
RX   PubMed=7590746; DOI=10.1006/geno.1995.1104;
RA   Marigo V., Roberts D.J., Lee S.M.K., Tsukurov O., Levi T., Gastier J.M.,
RA   Epstein D.J., Gilbert D.J., Copeland N.G., Seidman C.E., Jenkins N.A.,
RA   Seidman J.G., McMahon A.P., Tabin C.;
RT   "Cloning, expression, and chromosomal location of SHH and IHH: two human
RT   homologues of the Drosophila segment polarity gene hedgehog.";
RL   Genomics 28:44-51(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE OF 124-172.
RX   PubMed=7720571; DOI=10.1242/dev.120.11.3339;
RA   Chang D.T., Lopez A., von Kessler D.P., Chiang C., Simandl B.K., Zhao R.,
RA   Seldin M.F., Fallon J.F., Beachy P.A.;
RT   "Products, genetic linkage and limb patterning activity of a murine
RT   hedgehog gene.";
RL   Development 120:3339-3353(1994).
RN   [6]
RP   PALMITOYLATION AT CYS-28.
RX   PubMed=9593755; DOI=10.1074/jbc.273.22.14037;
RA   Pepinsky R.B., Zeng C., Wen D., Rayhorn P., Baker D.P., Williams K.P.,
RA   Bixler S.A., Ambrose C.M., Garber E.A., Miatkowski K., Taylor F.R.,
RA   Wang E.A., Galdes A.;
RT   "Identification of a palmitic acid-modified form of human Sonic hedgehog.";
RL   J. Biol. Chem. 273:14037-14045(1998).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-282.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND FUNCTION.
RX   PubMed=20839884; DOI=10.1021/pr100403q;
RA   Queiroz K.C., Tio R.A., Zeebregts C.J., Bijlsma M.F., Zijlstra F.,
RA   Badlou B., de Vries M., Ferreira C.V., Spek C.A., Peppelenbosch M.P.,
RA   Rezaee F.;
RT   "Human plasma very low density lipoprotein carries Indian hedgehog.";
RL   J. Proteome Res. 9:6052-6059(2010).
RN   [9]
RP   SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=24342078; DOI=10.1016/j.mod.2013.12.002;
RA   Pettigrew C.A., Asp E., Emerson C.P. Jr.;
RT   "A new role for Hedgehogs in juxtacrine signaling.";
RL   Mech. Dev. 131:137-149(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 29-193 IN COMPLEXES WITH CALCIUM
RP   IONS; ZINC IONS; BOC AND CDON, DOMAIN, AND INTERACTION WITH BOC AND CDON.
RX   PubMed=20519495; DOI=10.1074/jbc.m110.131680;
RA   Kavran J.M., Ward M.D., Oladosu O.O., Mulepati S., Leahy D.J.;
RT   "All mammalian Hedgehog proteins interact with cell adhesion molecule,
RT   down-regulated by oncogenes (CDO) and brother of CDO (BOC) in a conserved
RT   manner.";
RL   J. Biol. Chem. 285:24584-24590(2010).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.44 ANGSTROMS) OF 28-202 OF WILD TYPE AND VARIANTS
RP   BDA1 LYS-95; GLU-100 AND LYS-131 IN COMPLEX WITH ZINC IONS, FUNCTION,
RP   SUBUNIT, INTERACTION WITH PTCH1, SUBCELLULAR LOCATION, CHOLESTERYLATION,
RP   PALMITOYLATION, MUTAGENESIS OF GLU-95, DOMAIN, AND CHARACTERIZATION OF
RP   VARIANTS BDA1 LYS-95; ASN-100; GLU-100 AND LYS-131.
RX   PubMed=21537345; DOI=10.1038/cr.2011.76;
RA   Ma G., Yu J., Xiao Y., Chan D., Gao B., Hu J., He Y., Guo S., Zhou J.,
RA   Zhang L., Gao L., Zhang W., Kang Y., Cheah K.S., Feng G., Guo X., Wang Y.,
RA   Zhou C.Z., He L.;
RT   "Indian hedgehog mutations causing brachydactyly type A1 impair Hedgehog
RT   signal transduction at multiple levels.";
RL   Cell Res. 21:1343-1357(2011).
RN   [12]
RP   VARIANTS BDA1 LYS-95; GLU-100 AND LYS-131.
RX   PubMed=11455389; DOI=10.1038/ng577;
RA   Gao B., Guo J., She C., Shu A., Yang M., Tan Z., Yang X., Guo S., Feng G.,
RA   He L.;
RT   "Mutations in IHH, encoding Indian hedgehog, cause brachydactyly type A-
RT   1.";
RL   Nat. Genet. 28:386-388(2001).
RN   [13]
RP   VARIANT BDA1 ASN-100.
RX   PubMed=12384778; DOI=10.1007/s00439-002-0815-2;
RA   McCready M.E., Sweeney E., Fryer A.E., Donnai D., Baig A., Racacho L.,
RA   Warman M.L., Hunter A.G.W., Bulman D.E.;
RT   "A novel mutation in the IHH gene causes brachydactyly type A1: a 95-year-
RT   old mystery resolved.";
RL   Hum. Genet. 111:368-375(2002).
RN   [14]
RP   VARIANTS ACFD LEU-46 AND ALA-190.
RX   PubMed=12632327; DOI=10.1086/374318;
RA   Hellemans J., Coucke P.J., Giedion A., De Paepe A., Kramer P., Beemer F.,
RA   Mortier G.R.;
RT   "Homozygous mutations in IHH cause acrocapitofemoral dysplasia, an
RT   autosomal recessive disorder with cone-shaped epiphyses in hands and
RT   hips.";
RL   Am. J. Hum. Genet. 72:1040-1046(2003).
CC   -!- FUNCTION: [Indian hedgehog protein]: The C-terminal part of the indian
CC       hedgehog protein precursor displays an autoproteolysis and a
CC       cholesterol transferase activity (By similarity). Both activities
CC       result in the cleavage of the full-length protein into two parts
CC       followed by the covalent attachment of a cholesterol moiety to the C-
CC       terminal of the newly generated N-product (By similarity). Both
CC       activities occur in the reticulum endoplasmic (By similarity). Plays a
CC       role in hedgehog paracrine signaling (PubMed:24342078). Associated with
CC       the very-low-density lipoprotein (VLDL) particles to function as a
CC       circulating morphogen for endothelial cell integrity maintenance
CC       (PubMed:20839884). {ECO:0000250|UniProtKB:Q62226,
CC       ECO:0000269|PubMed:20839884, ECO:0000269|PubMed:24342078}.
CC   -!- FUNCTION: [Indian hedgehog protein N-product]: The dually lipidated
CC       indian hedgehog protein N-product is a morphogen which is essential for
CC       a variety of patterning events during development. Binds to the patched
CC       (PTCH1) receptor, which functions in association with smoothened (SMO),
CC       to activate the transcription of target genes (By similarity). Plays a
CC       role in morphogenesis of the skeleton by coordinating growth and
CC       differentiation of the endochondral skeleton (By similarity).
CC       Positively regulates PTHLH expression during endochondral bone
CC       formation preventing chondrocyte hypertrophy. In contrast, participates
CC       in normal chondrocyte proliferation in a PTHLH-independent pathway (By
CC       similarity). {ECO:0000250|UniProtKB:P97812,
CC       ECO:0000250|UniProtKB:Q15465, ECO:0000250|UniProtKB:Q62226}.
CC   -!- CATALYTIC ACTIVITY: [Indian hedgehog protein]:
CC       Reaction=cholesterol + glycyl-L-cysteinyl-[protein] + H(+) = [protein]-
CC         C-terminal glycyl cholesterol ester + N-terminal L-cysteinyl-
CC         [protein]; Xref=Rhea:RHEA:59504, Rhea:RHEA-COMP:12707, Rhea:RHEA-
CC         COMP:15369, Rhea:RHEA-COMP:15374, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16113, ChEBI:CHEBI:65250, ChEBI:CHEBI:143135,
CC         ChEBI:CHEBI:143140; Evidence={ECO:0000250|UniProtKB:Q62226};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:59505;
CC         Evidence={ECO:0000250|UniProtKB:Q62226};
CC   -!- SUBUNIT: [Indian hedgehog protein N-product]: Multimer.
CC       {ECO:0000269|PubMed:21537345}.
CC   -!- SUBUNIT: Interacts with BOC and CDON (PubMed:20519495). Interacts with
CC       PTCH1 (PubMed:21537345). Interacts with glypican GPC3 (By similarity).
CC       {ECO:0000250|UniProtKB:P97812, ECO:0000269|PubMed:20519495,
CC       ECO:0000269|PubMed:21537345}.
CC   -!- INTERACTION:
CC       Q14623; Q9BWV1: BOC; NbExp=2; IntAct=EBI-3918622, EBI-718555;
CC   -!- SUBCELLULAR LOCATION: [Indian hedgehog protein N-product]: Cell
CC       membrane {ECO:0000269|PubMed:21537345}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:Q62226}. Note=The N-product remains associated
CC       with the cell surface. {ECO:0000250|UniProtKB:Q15465}.
CC   -!- SUBCELLULAR LOCATION: [Indian hedgehog protein]: Endoplasmic reticulum
CC       membrane {ECO:0000250|UniProtKB:Q15465}. Golgi apparatus membrane
CC       {ECO:0000250|UniProtKB:Q15465}. Secreted {ECO:0000269|PubMed:24342078}.
CC       Note=Co-localizes with HHAT in the ER and Golgi membrane.
CC       {ECO:0000250|UniProtKB:Q15465}.
CC   -!- TISSUE SPECIFICITY: Expressed in embryonic lung, and in adult kidney
CC       and liver.
CC   -!- DOMAIN: [Indian hedgehog protein N-product]: Binds calcium and zinc
CC       ions; this stabilizes the protein fold and is essential for protein-
CC       protein interactions mediated by this domain.
CC       {ECO:0000269|PubMed:20519495, ECO:0000269|PubMed:21537345}.
CC   -!- PTM: [Indian hedgehog protein N-product]: Cholesterylation is required
CC       for N-product targeting to lipid rafts and multimerization.
CC       {ECO:0000269|PubMed:21537345}.
CC   -!- PTM: [Indian hedgehog protein]: The C-terminal domain displays an
CC       autoproteolysis activity and a cholesterol transferase activity (By
CC       similarity). Both activities result in the cleavage of the full-length
CC       protein and covalent attachment of a cholesterol moiety to the C-
CC       terminal of the newly generated N-product (By similarity). The N-
CC       product is the active species in both local and long-range signaling,
CC       whereas the C-product is degraded in the reticulum endoplasmic (By
CC       similarity). {ECO:0000250|UniProtKB:Q15465,
CC       ECO:0000250|UniProtKB:Q62226}.
CC   -!- PTM: [Indian hedgehog protein N-product]: N-palmitoylation by HHAT of
CC       N-product is required for indian hedgehog protein N-product
CC       multimerization and full activity. {ECO:0000269|PubMed:21537345,
CC       ECO:0000269|PubMed:9593755}.
CC   -!- DISEASE: Brachydactyly A1 (BDA1) [MIM:112500]: A form of brachydactyly.
CC       Brachydactyly defines a group of inherited malformations characterized
CC       by shortening of the digits due to abnormal development of the
CC       phalanges and/or the metacarpals. Brachydactyly type A1 is
CC       characterized by middle phalanges of all the digits rudimentary or
CC       fused with the terminal phalanges. The proximal phalanges of the thumbs
CC       and big toes are short. BDA1 inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:11455389, ECO:0000269|PubMed:12384778,
CC       ECO:0000269|PubMed:21537345}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Acrocapitofemoral dysplasia (ACFD) [MIM:607778]: An autosomal
CC       recessive disorder characterized by short stature of variable severity
CC       with postnatal onset. The most constant radiographic abnormalities are
CC       observed in the tubular bones of the hands and in the proximal part of
CC       the femur. Cone-shaped epiphyses or a similar epiphyseal configuration
CC       with premature epimetaphyseal fusion result in shortening of the
CC       skeletal components involved. Cone-shaped epiphyses are also present to
CC       a variable extent at the shoulders, knees and ankles.
CC       {ECO:0000269|PubMed:12632327}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the hedgehog family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB018076; BAA33523.2; -; Genomic_DNA.
DR   EMBL; CH471063; EAW70675.1; -; Genomic_DNA.
DR   EMBL; BC034757; AAH34757.2; -; mRNA.
DR   EMBL; BC136587; AAI36588.1; -; mRNA.
DR   EMBL; BC136588; AAI36589.1; -; mRNA.
DR   EMBL; L38517; AAA62178.1; -; mRNA.
DR   CCDS; CCDS33380.1; -.
DR   RefSeq; NP_002172.2; NM_002181.3.
DR   PDB; 3K7G; X-ray; 1.50 A; B=28-202.
DR   PDB; 3K7H; X-ray; 1.50 A; B=28-202.
DR   PDB; 3K7I; X-ray; 1.44 A; B=28-202.
DR   PDB; 3K7J; X-ray; 1.90 A; B=28-202.
DR   PDB; 3N1F; X-ray; 1.60 A; A/B=29-193.
DR   PDB; 3N1M; X-ray; 1.69 A; B=29-193.
DR   PDB; 3N1O; X-ray; 2.55 A; A/B/C=29-193.
DR   PDB; 3N1P; X-ray; 2.70 A; B=29-193.
DR   PDBsum; 3K7G; -.
DR   PDBsum; 3K7H; -.
DR   PDBsum; 3K7I; -.
DR   PDBsum; 3K7J; -.
DR   PDBsum; 3N1F; -.
DR   PDBsum; 3N1M; -.
DR   PDBsum; 3N1O; -.
DR   PDBsum; 3N1P; -.
DR   AlphaFoldDB; Q14623; -.
DR   SMR; Q14623; -.
DR   BioGRID; 109765; 10.
DR   IntAct; Q14623; 4.
DR   STRING; 9606.ENSP00000295731; -.
DR   MEROPS; C46.003; -.
DR   GlyGen; Q14623; 1 site.
DR   iPTMnet; Q14623; -.
DR   PhosphoSitePlus; Q14623; -.
DR   BioMuta; IHH; -.
DR   DMDM; 33112634; -.
DR   MassIVE; Q14623; -.
DR   MaxQB; Q14623; -.
DR   PaxDb; Q14623; -.
DR   PeptideAtlas; Q14623; -.
DR   PRIDE; Q14623; -.
DR   ProteomicsDB; 60073; -.
DR   Antibodypedia; 3977; 529 antibodies from 37 providers.
DR   DNASU; 3549; -.
DR   Ensembl; ENST00000295731.7; ENSP00000295731.5; ENSG00000163501.7.
DR   GeneID; 3549; -.
DR   KEGG; hsa:3549; -.
DR   MANE-Select; ENST00000295731.7; ENSP00000295731.5; NM_002181.4; NP_002172.2.
DR   UCSC; uc002vjo.3; human.
DR   CTD; 3549; -.
DR   DisGeNET; 3549; -.
DR   GeneCards; IHH; -.
DR   HGNC; HGNC:5956; IHH.
DR   HPA; ENSG00000163501; Tissue enhanced (endometrium, intestine, stomach).
DR   MalaCards; IHH; -.
DR   MIM; 112500; phenotype.
DR   MIM; 600726; gene.
DR   MIM; 607778; phenotype.
DR   neXtProt; NX_Q14623; -.
DR   OpenTargets; ENSG00000163501; -.
DR   Orphanet; 63446; Acrocapitofemoral dysplasia.
DR   Orphanet; 93388; Brachydactyly type A1.
DR   PharmGKB; PA29769; -.
DR   VEuPathDB; HostDB:ENSG00000163501; -.
DR   eggNOG; KOG3638; Eukaryota.
DR   GeneTree; ENSGT00940000159207; -.
DR   HOGENOM; CLU_034686_0_0_1; -.
DR   InParanoid; Q14623; -.
DR   OMA; APAVRGC; -.
DR   OrthoDB; 1169356at2759; -.
DR   PhylomeDB; Q14623; -.
DR   TreeFam; TF106458; -.
DR   PathwayCommons; Q14623; -.
DR   Reactome; R-HSA-373080; Class B/2 (Secretin family receptors).
DR   Reactome; R-HSA-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-HSA-5362798; Release of Hh-Np from the secreting cell.
DR   Reactome; R-HSA-5632681; Ligand-receptor interactions.
DR   Reactome; R-HSA-5632684; Hedgehog 'on' state.
DR   Reactome; R-HSA-5635838; Activation of SMO.
DR   Reactome; R-HSA-5658034; HHAT G278V doesn't palmitoylate Hh-Np.
DR   Reactome; R-HSA-8941284; RUNX2 regulates chondrocyte maturation.
DR   SignaLink; Q14623; -.
DR   SIGNOR; Q14623; -.
DR   BioGRID-ORCS; 3549; 6 hits in 1066 CRISPR screens.
DR   EvolutionaryTrace; Q14623; -.
DR   GeneWiki; IHH_(protein); -.
DR   GenomeRNAi; 3549; -.
DR   Pharos; Q14623; Tbio.
DR   PRO; PR:Q14623; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; Q14623; protein.
DR   Bgee; ENSG00000163501; Expressed in mucosa of transverse colon and 70 other tissues.
DR   Genevisible; Q14623; HS.
DR   GO; GO:0031012; C:extracellular matrix; IEA:Ensembl.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0005113; F:patched binding; IDA:UniProtKB.
DR   GO; GO:0008233; F:peptidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0045453; P:bone resorption; IEA:Ensembl.
DR   GO; GO:0001569; P:branching involved in blood vessel morphogenesis; IEA:Ensembl.
DR   GO; GO:0060220; P:camera-type eye photoreceptor cell fate commitment; IEA:Ensembl.
DR   GO; GO:0051216; P:cartilage development; IMP:AgBase.
DR   GO; GO:0001708; P:cell fate specification; IBA:GO_Central.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0007267; P:cell-cell signaling; IEA:InterPro.
DR   GO; GO:0003413; P:chondrocyte differentiation involved in endochondral bone morphogenesis; IEA:Ensembl.
DR   GO; GO:0035988; P:chondrocyte proliferation; IEA:Ensembl.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; IEA:Ensembl.
DR   GO; GO:0048557; P:embryonic digestive tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IMP:AgBase.
DR   GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR   GO; GO:0072498; P:embryonic skeletal joint development; IEA:Ensembl.
DR   GO; GO:0003382; P:epithelial cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0090136; P:epithelial cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0060323; P:head morphogenesis; IEA:Ensembl.
DR   GO; GO:0001947; P:heart looping; ISS:BHF-UCL.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0016539; P:intein-mediated protein splicing; IEA:InterPro.
DR   GO; GO:0097421; P:liver regeneration; IEA:Ensembl.
DR   GO; GO:0060135; P:maternal process involved in female pregnancy; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0046639; P:negative regulation of alpha-beta T cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0032331; P:negative regulation of chondrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0048074; P:negative regulation of eye pigmentation; IEA:Ensembl.
DR   GO; GO:0033088; P:negative regulation of immature T cell proliferation in thymus; ISS:BHF-UCL.
DR   GO; GO:0033085; P:negative regulation of T cell differentiation in thymus; ISS:BHF-UCL.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0031016; P:pancreas development; IEA:Ensembl.
DR   GO; GO:0046638; P:positive regulation of alpha-beta T cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0002053; P:positive regulation of mesenchymal cell proliferation; IEA:Ensembl.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; ISS:BHF-UCL.
DR   GO; GO:0033089; P:positive regulation of T cell differentiation in thymus; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0016540; P:protein autoprocessing; IEA:InterPro.
DR   GO; GO:0006029; P:proteoglycan metabolic process; IEA:Ensembl.
DR   GO; GO:0010468; P:regulation of gene expression; IBA:GO_Central.
DR   GO; GO:0040008; P:regulation of growth; IEA:Ensembl.
DR   GO; GO:0032355; P:response to estradiol; IEA:Ensembl.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0003406; P:retinal pigment epithelium development; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IMP:UniProtKB.
DR   GO; GO:0048745; P:smooth muscle tissue development; IEA:Ensembl.
DR   GO; GO:0007224; P:smoothened signaling pathway; IDA:UniProtKB.
DR   GO; GO:0061053; P:somite development; ISS:BHF-UCL.
DR   GO; GO:0030704; P:vitelline membrane formation; IEA:Ensembl.
DR   Gene3D; 3.30.1380.10; -; 1.
DR   InterPro; IPR001657; Hedgehog.
DR   InterPro; IPR001767; Hedgehog_Hint.
DR   InterPro; IPR009045; Hedgehog_sig/DD-Pept_Zn-bd_sf.
DR   InterPro; IPR000320; Hedgehog_signalling_dom.
DR   InterPro; IPR003586; Hint_dom_C.
DR   InterPro; IPR003587; Hint_dom_N.
DR   InterPro; IPR036844; Hint_dom_sf.
DR   InterPro; IPR033385; IHH.
DR   InterPro; IPR006141; Intein_N.
DR   PANTHER; PTHR11889:SF39; PTHR11889:SF39; 1.
DR   Pfam; PF01085; HH_signal; 1.
DR   Pfam; PF01079; Hint; 1.
DR   PIRSF; PIRSF009400; Peptidase_C46; 1.
DR   PRINTS; PR00632; SONICHHOG.
DR   SMART; SM00305; HintC; 1.
DR   SMART; SM00306; HintN; 1.
DR   SUPFAM; SSF51294; SSF51294; 1.
DR   SUPFAM; SSF55166; SSF55166; 1.
DR   PROSITE; PS50817; INTEIN_N_TER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Autocatalytic cleavage; Calcium; Cell membrane;
KW   Developmental protein; Disease variant; Endoplasmic reticulum;
KW   Glycoprotein; Golgi apparatus; Hydrolase; Lipoprotein; Membrane;
KW   Metal-binding; Palmitate; Protease; Reference proteome; Secreted; Signal;
KW   Zinc.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000305"
FT   CHAIN           28..411
FT                   /note="Indian hedgehog protein"
FT                   /id="PRO_0000013229"
FT   CHAIN           28..202
FT                   /note="Indian hedgehog protein N-product"
FT                   /id="PRO_0000013230"
FT   BINDING         94
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         95
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         95
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         100
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         130
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         131
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         131
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         134
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         136
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000269|PubMed:20519495"
FT   BINDING         145
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:20519495,
FT                   ECO:0000269|PubMed:21537345"
FT   BINDING         152
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:20519495,
FT                   ECO:0000269|PubMed:21537345"
FT   BINDING         187
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /evidence="ECO:0000269|PubMed:20519495,
FT                   ECO:0000269|PubMed:21537345"
FT   SITE            202..203
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q02936"
FT   SITE            248
FT                   /note="Involved in cholesterol transfer"
FT                   /evidence="ECO:0000250|UniProtKB:Q02936"
FT   SITE            272
FT                   /note="Involved in auto-cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q02936"
FT   SITE            275
FT                   /note="Essential for auto-cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:Q02936"
FT   LIPID           28
FT                   /note="N-palmitoyl cysteine"
FT                   /evidence="ECO:0000305|PubMed:9593755"
FT   LIPID           202
FT                   /note="Cholesterol glycine ester"
FT                   /evidence="ECO:0000250|UniProtKB:Q02936"
FT   CARBOHYD        282
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   VARIANT         46
FT                   /note="P -> L (in ACFD; dbSNP:rs121917856)"
FT                   /evidence="ECO:0000269|PubMed:12632327"
FT                   /id="VAR_015981"
FT   VARIANT         95
FT                   /note="E -> K (in BDA1; decreases the stability of the
FT                   indian hedgehog protein N-product; dbSNP:rs121917852)"
FT                   /evidence="ECO:0000269|PubMed:11455389,
FT                   ECO:0000269|PubMed:21537345"
FT                   /id="VAR_015982"
FT   VARIANT         100
FT                   /note="D -> E (in BDA1; decreases the stability of the
FT                   indian hedgehog protein N-product; dbSNP:rs121917854)"
FT                   /evidence="ECO:0000269|PubMed:11455389,
FT                   ECO:0000269|PubMed:21537345"
FT                   /id="VAR_015983"
FT   VARIANT         100
FT                   /note="D -> N (in BDA1; decreases the stability of the
FT                   indian hedgehog protein N-product; dbSNP:rs121917855)"
FT                   /evidence="ECO:0000269|PubMed:12384778,
FT                   ECO:0000269|PubMed:21537345"
FT                   /id="VAR_015984"
FT   VARIANT         131
FT                   /note="E -> K (in BDA1; no effect on the stability of the
FT                   indian hedgehog protein N-product; dbSNP:rs121917853)"
FT                   /evidence="ECO:0000269|PubMed:11455389,
FT                   ECO:0000269|PubMed:21537345"
FT                   /id="VAR_015985"
FT   VARIANT         190
FT                   /note="V -> A (in ACFD; dbSNP:rs121917857)"
FT                   /evidence="ECO:0000269|PubMed:12632327"
FT                   /id="VAR_015986"
FT   MUTAGEN         95
FT                   /note="E->G: Increases the lysosomal degradation of the
FT                   indian hedgehog protein N-product."
FT                   /evidence="ECO:0000269|PubMed:21537345"
FT   CONFLICT        100
FT                   /note="D -> R (in Ref. 4; AAA62178)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        246
FT                   /note="F -> L (in Ref. 1; BAA33523)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        309
FT                   /note="V -> A (in Ref. 1; BAA33523)"
FT                   /evidence="ECO:0000305"
FT   STRAND          52..56
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   TURN            61..64
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   STRAND          73..75
FT                   /evidence="ECO:0007829|PDB:3N1P"
FT   HELIX           76..80
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   STRAND          89..91
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   STRAND          96..98
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   HELIX           99..101
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   HELIX           105..121
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   STRAND          127..131
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   HELIX           144..147
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   STRAND          150..155
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   HELIX           160..162
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   HELIX           163..172
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   STRAND          176..182
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   STRAND          185..189
FT                   /evidence="ECO:0007829|PDB:3K7I"
FT   STRAND          193..195
FT                   /evidence="ECO:0007829|PDB:3K7I"
SQ   SEQUENCE   411 AA;  45251 MW;  4DA90C83F5ABF758 CRC64;
     MSPARLRPRL HFCLVLLLLL VVPAAWGCGP GRVVGSRRRP PRKLVPLAYK QFSPNVPEKT
     LGASGRYEGK IARSSERFKE LTPNYNPDII FKDEENTGAD RLMTQRCKDR LNSLAISVMN
     QWPGVKLRVT EGWDEDGHHS EESLHYEGRA VDITTSDRDR NKYGLLARLA VEAGFDWVYY
     ESKAHVHCSV KSEHSAAAKT GGCFPAGAQV RLESGARVAL SAVRPGDRVL AMGEDGSPTF
     SDVLIFLDRE PHRLRAFQVI ETQDPPRRLA LTPAHLLFTA DNHTEPAARF RATFASHVQP
     GQYVLVAGVP GLQPARVAAV STHVALGAYA PLTKHGTLVV EDVVASCFAA VADHHLAQLA
     FWPLRLFHSL AWGSWTPGEG VHWYPQLLYR LGRLLLEEGS FHPLGMSGAG S
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024